Coronaviruses in Avian Species – Review with Focus on Epidemiology and Diagnosis in Wild Birds
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Predicting Hosts Based on Early SARS-Cov-2 Samples And
www.nature.com/scientificreports OPEN Predicting hosts based on early SARS‑CoV‑2 samples and analyzing the 2020 pandemic Qian Guo1,2,3,7, Mo Li4,7, Chunhui Wang4,7, Jinyuan Guo1,3,7, Xiaoqing Jiang1,2,5,7, Jie Tan1, Shufang Wu1,2, Peihong Wang1, Tingting Xiao6, Man Zhou1,2, Zhencheng Fang1,2, Yonghong Xiao6* & Huaiqiu Zhu1,2,3,5* The SARS‑CoV‑2 pandemic has raised concerns in the identifcation of the hosts of the virus since the early stages of the outbreak. To address this problem, we proposed a deep learning method, DeepHoF, based on extracting viral genomic features automatically, to predict the host likelihood scores on fve host types, including plant, germ, invertebrate, non‑human vertebrate and human, for novel viruses. DeepHoF made up for the lack of an accurate tool, reaching a satisfactory AUC of 0.975 in the fve‑ classifcation, and could make a reliable prediction for the novel viruses without close neighbors in phylogeny. Additionally, to fll the gap in the efcient inference of host species for SARS‑CoV‑2 using existing tools, we conducted a deep analysis on the host likelihood profle calculated by DeepHoF. Using the isolates sequenced in the earliest stage of the COVID‑19 pandemic, we inferred that minks, bats, dogs and cats were potential hosts of SARS‑CoV‑2, while minks might be one of the most noteworthy hosts. Several genes of SARS‑CoV‑2 demonstrated their signifcance in determining the host range. Furthermore, a large‑scale genome analysis, based on DeepHoF’s computation for the later pandemic in 2020, disclosed the uniformity of host range among SARS‑CoV‑2 samples and the strong association of SARS‑CoV‑2 between humans and minks. -
Review a Review of Coronavirus Infection in the Central Nervous
Review J Vet Intern Med 2001;15:438–444 A Review of Coronavirus Infection in the Central Nervous System of Cats and Mice Janet E. Foley and Christian Leutenegger Feline infectious peritonitis (FIP) is a common cause of death in cats. Management of this disease has been hampered by difficulties identifying the infection and determining the immunological status of affected cats and by high variability in the clinical, patho- logical, and immunological characteristics of affected cats. Neurological FIP, which is much more homogeneous than systemic effusive or noneffusive FIP, appears to be a good model for establishing the basic features of FIP immunopathogenesis. Very little information is available about the immunopathogenesis of neurologic FIP, and it is reasonable to use research from the well- characterized mouse hepatitis virus (MHV) immune-mediated encephalitis system, as a template for FIP investigation, and to contrast findings from the MHV model with those of FIP. It is expected that the immunopathogenic mechanisms will have important similarities. Such comparative research may lead to better understanding of FIP immunopathogenesis and rational prospects for management of this frustrating disease. Key words: Cats; Feline infectious peritonitis; Mouse hepatitis virus; Neurological disease. eline infectious peritonitis (FIP) is a fatal, immune-me- membrane), N (nucleocapsid), and S (spike glycoprotein), F diated disease produced as a result of infection of which is post-translationally modified to S1 and S2.8 The macrophages by mutant feline coronavirus strains (FIPVs). MHV genome, however, also codes for an HE protein and The severity of FIP is determined by virus strain and by does not contain a 7b ORF. -
Broad Receptor Engagement of an Emerging Global Coronavirus May Potentiate Its Diverse Cross-Species Transmissibility
Broad receptor engagement of an emerging global coronavirus may potentiate its diverse cross-species transmissibility Wentao Lia,1, Ruben J. G. Hulswita,1, Scott P. Kenneyb,1, Ivy Widjajaa, Kwonil Jungb, Moyasar A. Alhamob, Brenda van Dierena, Frank J. M. van Kuppevelda, Linda J. Saifb,2, and Berend-Jan Boscha,2 aVirology Division, Department of Infectious Diseases & Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands; and bDepartment of Veterinary Preventive Medicine, Food Animal Health Research Program, Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, OH 44691 Contributed by Linda J. Saif, April 12, 2018 (sent for review February 15, 2018; reviewed by Tom Gallagher and Stefan Pöhlmann) Porcine deltacoronavirus (PDCoV), identified in 2012, is a common greatly increase the potential for successful adaptation to a new enteropathogen of swine with worldwide distribution. The source host (6, 12). A pivotal criterion of cross-species transmission and evolutionary history of this virus is, however, unknown. concerns the ability of a virus to engage a receptor within the PDCoV belongs to the Deltacoronavirus genus that comprises pre- novel host, which for CoVs, is determined by the receptor dominantly avian CoV. Phylogenetic analysis suggests that PDCoV specificity of the viral spike (S) entry protein. originated relatively recently from a host-switching event be- The porcine deltacoronavirus (PDCoV) is a recently discov- tween birds and mammals. Insight into receptor engagement by ered CoV of unknown origin. PDCoV (species name coronavirus PDCoV may shed light into such an exceptional phenomenon. Here HKU15) was identified in Hong Kong in pigs in the late 2000s we report that PDCoV employs host aminopeptidase N (APN) as an (13) and has since been detected in swine populations in various entry receptor and interacts with APN via domain B of its spike (S) countries worldwide (14–24). -
On the Coronaviruses and Their Associations with the Aquatic Environment and Wastewater
water Review On the Coronaviruses and Their Associations with the Aquatic Environment and Wastewater Adrian Wartecki 1 and Piotr Rzymski 2,* 1 Faculty of Medicine, Poznan University of Medical Sciences, 60-812 Pozna´n,Poland; [email protected] 2 Department of Environmental Medicine, Poznan University of Medical Sciences, 60-806 Pozna´n,Poland * Correspondence: [email protected] Received: 24 April 2020; Accepted: 2 June 2020; Published: 4 June 2020 Abstract: The outbreak of Coronavirus Disease 2019 (COVID-19), a severe respiratory disease caused by betacoronavirus SARS-CoV-2, in 2019 that further developed into a pandemic has received an unprecedented response from the scientific community and sparked a general research interest into the biology and ecology of Coronaviridae, a family of positive-sense single-stranded RNA viruses. Aquatic environments, lakes, rivers and ponds, are important habitats for bats and birds, which are hosts for various coronavirus species and strains and which shed viral particles in their feces. It is therefore of high interest to fully explore the role that aquatic environments may play in coronavirus spread, including cross-species transmissions. Besides the respiratory tract, coronaviruses pathogenic to humans can also infect the digestive system and be subsequently defecated. Considering this, it is pivotal to understand whether wastewater can play a role in their dissemination, particularly in areas with poor sanitation. This review provides an overview of the taxonomy, molecular biology, natural reservoirs and pathogenicity of coronaviruses; outlines their potential to survive in aquatic environments and wastewater; and demonstrates their association with aquatic biota, mainly waterfowl. It also calls for further, interdisciplinary research in the field of aquatic virology to explore the potential hotspots of coronaviruses in the aquatic environment and the routes through which they may enter it. -
1099.Full.Pdf
Type I IFN-Mediated Protection of Macrophages and Dendritic Cells Secures Control of Murine Coronavirus Infection This information is current as Luisa Cervantes-Barragán, Ulrich Kalinke, Roland Züst, of September 23, 2021. Martin König, Boris Reizis, Constantino López-Macías, Volker Thiel and Burkhard Ludewig J Immunol 2009; 182:1099-1106; ; doi: 10.4049/jimmunol.182.2.1099 http://www.jimmunol.org/content/182/2/1099 Downloaded from References This article cites 43 articles, 23 of which you can access for free at: http://www.jimmunol.org/content/182/2/1099.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 23, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Type I IFN-Mediated Protection of Macrophages and Dendritic Cells Secures Control of Murine Coronavirus Infection1 Luisa Cervantes-Barraga´n,*† Ulrich Kalinke,‡ Roland Zu¨st,* Martin König,‡ Boris Reizis,§ Constantino Lo´pez-Macías,† Volker Thiel,* and Burkhard Ludewig2* The swift production of type I IFNs is one of the fundamental aspects of innate immune responses against viruses. -
Hydroxychloroquine Or Chloroquine for Treating Coronavirus Disease 2019 (COVID-19) – a PROTOCOL for a Systematic Review of Individual Participant Data
Hydroxychloroquine or Chloroquine for treating Coronavirus Disease 2019 (COVID-19) – a PROTOCOL for a systematic review of Individual Participant Data Authors Fontes LE, Riera R, Miranda E, Oke J, Heneghan CJ, Aronson JK, Pacheco RL, Martimbianco ALC, Nunan D BACKGROUND In the face of the pandemic of SARS CoV2, urgent research is needed to test potential therapeutic agents against the disease. Reliable research shall inform clinical decision makers. Currently, there are several studies testing the efficacy and safety profiles of different pharmacological interventions. Among these drugs, we can cite antimalarial, antivirals, biological drugs, interferon, etc. As of 6 April 2020 there are three published reportsand 100 ongoing trials testing hydroxychloroquine/chloroquine alone or in association with other drugs for COVID-19. This prospective systematic review with Individual Participant data aims to assess the rigour of the best-available evidence for hydroxychloroquine or chloroquine as treatment for COVID-19 infection. The PICO framework is: P: adults with COVID-19 infection I: chloroquine or hydroxychloroquine (alone or in association) C: placebo, other active treatments, usual standard care without antimalarials O: efficacy and safety outcomes OBJECTIVES To assess the effects (benefits and harms) of chloroquine or hydroxychloroquine for the treatment of COVID-19 infection. METHODS Criteria for considering studies for this review Types of studies We shall include randomized controlled trials (RCTs) with a parallel design. We intend to include even small trials (<50 participants), facing the urgent need for evidence to respond to the current pandemic. Quasi-randomized, non-randomized, or observational studies will be excluded due to a higher risk of confounding and selection bias (1). -
Alignment-Free Machine Learning Approaches for the Lethality Prediction of Potential Novel Human-Adapted Coronavirus Using Genomic Nucleotide
bioRxiv preprint doi: https://doi.org/10.1101/2020.07.15.176933; this version posted July 15, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Alignment-free machine learning approaches for the lethality prediction of potential novel human-adapted coronavirus using genomic nucleotide Rui Yin1,*, Zihan Luo2, Chee Keong Kwoh1 1 Biomedical Informatics Lab, Nanyang Technological University, Singapore, Singapore 2 School of Electronic Information and Communications, Huazhong University of Science and Technology, Wuhan, Hubei Province, China * [email protected] Abstract A newly emerging novel coronavirus appeared and rapidly spread worldwide and World 1 Health Organization declared a pandemic on March 11, 2020. The roles and 2 characteristics of coronavirus have captured much attention due to its power of causing 3 a wide variety of infectious diseases, from mild to severe on humans. The detection of 4 the lethality of human coronavirus is key to estimate the viral toxicity and provide 5 perspective for treatment. We developed alignment-free machine learning approaches for 6 an ultra-fast and highly accurate prediction of the lethality of potential human-adapted 7 coronavirus using genomic nucleotide. We performed extensive experiments through six 8 different feature transformation and machine learning algorithms in combination with 9 digital signal processing to infer the lethality of possible future novel coronaviruses 10 using previous existing strains. The results tested on SARS-CoV, MERS-Cov and 11 SARS-CoV-2 datasets show an average 96.7% prediction accuracy. -
Complete Sections As Applicable
This form should be used for all taxonomic proposals. Please complete all those modules that are applicable (and then delete the unwanted sections). For guidance, see the notes written in blue and the separate document “Help with completing a taxonomic proposal” Please try to keep related proposals within a single document; you can copy the modules to create more than one genus within a new family, for example. MODULE 1: TITLE, AUTHORS, etc (to be completed by ICTV Code assigned: 2010.023a-dV officers) Short title: A new genus and three new species in the subfamily Coronavirinae (e.g. 6 new species in the genus Zetavirus) Modules attached 1 2 3 4 5 (modules 1 and 9 are required) 6 7 8 9 Author(s) with e-mail address(es) of the proposer: Raoul J. de Groot and Alexander E. Gorbalenya List the ICTV study group(s) that have seen this proposal: A list of study groups and contacts is provided at http://www.ictvonline.org/subcommittees.asp . If Submission on behalf of the Coronavirus Study in doubt, contact the appropriate subcommittee Group. Authors are CSG members (R.J de chair (fungal, invertebrate, plant, prokaryote or Groot, Chair) vertebrate viruses) ICTV-EC or Study Group comments and response of the proposer: Date first submitted to ICTV: Date of this revision (if different to above): Page 1 of 5 MODULE 2: NEW SPECIES Code 2010.023aV (assigned by ICTV officers) To create new species within: Genus: Deltacoronavirus (new) Subfamily: Coronavirinae Family: Coronaviridae Order: Nidovirales And name the new species: GenBank sequence accession number(s) of reference isolate: Bulbul coronavirus HKU11 [FJ376619] Thrush coronavirus HKU12 [FJ376621=NC_011549] Munia coronavirus HKU13 [FJ376622=NC_011550] Reasons to justify the creation and assignment of the new species: According to the demarcation criteria as outlined in Module 3 and agreed upon by the Coronavirus Study Group, the new coronaviruses isolated from Bulbul, Thrush and Munia are representatives of separates species. -
Coronaviruses Post-SARS: Update on Replication and Pathogenesis
REVIEWS Coronaviruses post-SARS: update on replication and pathogenesis Stanley Perlman and Jason Netland Abstract | Although coronaviruses were first identified nearly 60 years ago, they only received notoriety in 2003 when one of their members was identified as the aetiological agent of severe acute respiratory syndrome. Previously these viruses were known to be important agents of respiratory and enteric infections of domestic and companion animals and to cause approximately 15% of all cases of the common cold. This Review focuses on recent advances in our understanding of the mechanisms of coronavirus replication, interactions with the host immune response and disease pathogenesis. It also highlights the recent identification of numerous novel coronaviruses and the propensity of this virus family to cross species barriers. Prothrombinase Coronaviruses, a genus in the Coronaviridae family (order encode an additional haemagglutinin-esterase (HE) pro- Molecule that cleaves Nidovirales; FIG. 1), are pleomorphic, enveloped viruses. tein (FIG. 2a,b). The HE protein, which may be involved thrombin, thereby initiating the Coronaviruses gained prominence during the severe acute in virus entry or egress, is not required for replica- coagulation cascade. respiratory syndrome (SARS) outbreaks of 2002–2003 tion, but appears to be important for infection of the (REF. 1). The viral membrane contains the transmembrane natural host5. (M) glycoprotein, the spike (S) glycoprotein and the enve- Receptors for several coronaviruses have been iden- lope (E) protein, and surrounds a disordered or flexible, tified (TABLE 1). The prototypical coronavirus, mouse probably helical, nucleocapsid2,3. The viral membrane is hepatitis virus (MHV), uses CEACAM1a, a member of unusually thick, probably because the carboxy-terminal the murine carcinoembryonic antigen family, to enter region of the M protein forms an extra internal layer, as cells. -
The COVID-19 Pandemic: a Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control
Journal of Clinical Medicine Review The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control Yosra A. Helmy 1,2,* , Mohamed Fawzy 3,*, Ahmed Elaswad 4, Ahmed Sobieh 5, Scott P. Kenney 1 and Awad A. Shehata 6,7 1 Department of Veterinary Preventive Medicine, Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, OH 44691, USA; [email protected] 2 Department of Animal Hygiene, Zoonoses and Animal Ethology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt 3 Department of Virology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt 4 Department of Animal Wealth Development, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt; [email protected] 5 Department of Radiology, University of Massachusetts Medical School, Worcester, MA 01655, USA; [email protected] 6 Avian and Rabbit Diseases Department, Faculty of Veterinary Medicine, Sadat City University, Sadat 32897, Egypt; [email protected] 7 Research and Development Section, PerNaturam GmbH, 56290 Gödenroth, Germany * Correspondence: [email protected] (Y.A.H.); [email protected] (M.F.) Received: 18 March 2020; Accepted: 21 April 2020; Published: 24 April 2020 Abstract: A pneumonia outbreak with unknown etiology was reported in Wuhan, Hubei province, China, in December 2019, associated with the Huanan Seafood Wholesale Market. The causative agent of the outbreak was identified by the WHO as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), producing the disease named coronavirus disease-2019 (COVID-19). The virus is closely related (96.3%) to bat coronavirus RaTG13, based on phylogenetic analysis. -
Animal Reservoirs and Hosts for Emerging Alphacoronaviruses and Betacoronaviruses
Article DOI: https://doi.org/10.3201/eid2704.203945 Animal Reservoirs and Hosts for Emerging Alphacoronaviruses and Betacoronaviruses Appendix Appendix Table. Citations for in-text tables, by coronavirus and host category Pathogen (abbreviation) Category Table Reference Alphacoronavirus 1 (ACoV1); strain canine enteric coronavirus Receptor 1 (1) (CCoV) Reservoir host(s) 2 (2) Spillover host(s) 2 (3–6) Clinical manifestation 3 (3–9) Alphacoronavirus 1 (ACoV1); strain feline infectious peritonitis Receptor 1 (10) virus (FIPV) Reservoir host(s) 2 (11,12) Spillover host(s) 2 (13–15) Susceptible host 2 (16) Clinical manifestation 3 (7,9,17,18) Bat coronavirus HKU10 Receptor 1 (19) Reservoir host(s) 2 (20) Spillover host(s) 2 (21) Clinical manifestation 3 (9,21) Ferret systemic coronavirus (FRSCV) Receptor 1 (22) Reservoir host(s) 2 (23) Spillover host(s) 2 (24,25) Clinical manifestation 3 (9,26) Human coronavirus NL63 Receptor 1 (27) Reservoir host(s) 2 (28) Spillover host(s) 2 (29,30) Nonsusceptible host(s) 2 (31) Clinical manifestation 3 (9,32–34) Human coronavirus 229E Receptor 1 (35) Reservoir host(s) 2 (28,36,37) Intermediate host(s) 2 (38) Spillover host(s) 2 (39,40) Susceptible host(s) 2 (41) Clinical manifestation 3 (9,32,34,38,41–43) Porcine epidemic diarrhea virus (PEDV) Receptor 1 (44,45) Reservoir host(s) 2 (32,46) Spillover host(s) 2 (47) Clinical manifestation 3 (7,9,32,48) Rhinolophus bat coronavirus HKU2; strain swine acute Receptor 1 (49) diarrhea syndrome coronavirus (SADS-CoV) Reservoir host(s) 2 (49) Spillover host(s) 2 -
Drawing Comparisons Between SARS-Cov-2 and the Animal Coronaviruses
microorganisms Review Drawing Comparisons between SARS-CoV-2 and the Animal Coronaviruses Souvik Ghosh 1,* and Yashpal S. Malik 2 1 Department of Biomedical Sciences, Ross University School of Veterinary Medicine, Basseterre 334, Saint Kitts and Nevis 2 College of Animal Biotechnology, Guru Angad Dev Veterinary and Animal Science University, Ludhiana 141004, India; [email protected] * Correspondence: [email protected] or [email protected]; Tel.: +1-869-4654161 (ext. 401-1202) Received: 23 September 2020; Accepted: 19 November 2020; Published: 23 November 2020 Abstract: The COVID-19 pandemic, caused by a novel zoonotic coronavirus (CoV), SARS-CoV-2, has infected 46,182 million people, resulting in 1,197,026 deaths (as of 1 November 2020), with devastating and far-reaching impacts on economies and societies worldwide. The complex origin, extended human-to-human transmission, pathogenesis, host immune responses, and various clinical presentations of SARS-CoV-2 have presented serious challenges in understanding and combating the pandemic situation. Human CoVs gained attention only after the SARS-CoV outbreak of 2002–2003. On the other hand, animal CoVs have been studied extensively for many decades, providing a plethora of important information on their genetic diversity, transmission, tissue tropism and pathology, host immunity, and therapeutic and prophylactic strategies, some of which have striking resemblance to those seen with SARS-CoV-2. Moreover, the evolution of human CoVs, including SARS-CoV-2, is intermingled with those of animal CoVs. In this comprehensive review, attempts have been made to compare the current knowledge on evolution, transmission, pathogenesis, immunopathology, therapeutics, and prophylaxis of SARS-CoV-2 with those of various animal CoVs.